by William J. Walsh, PhD
I’m pleased to announce that my new book NUTRIENT POWER (Skyhorse Publishing, Inc.) has been completed. The book won’t be released to Amazon and bookstores until September, but early copies are now available here.
The book presents a science-based nutrient therapy system that can help millions of patients throughout the world. The text is aimed at doctors, researchers, and families challenged by depression, anxiety, schizophrenia, ADHD, autism, and other brain disorders. This approach recognizes that nutrient imbalances can alter brain levels of key neurotransmitters, disrupt gene expression of proteins and enzymes, and cripple the body’s protection against environmental toxins.
The book demonstrates that depression, schizophrenia, and ADHD are umbrella terms that encompass disorders with widely differing brain chemistries and symptoms. Nutrient therapies tailored for five depression biotypes, three schizophrenia biotypes, and various ADHD conditions are presented along with several case histories.
Other book highlights include the Walsh Theory of Schizophrenia, an epigenetic model of autism, a promising new Alzheimer’s treatment, and recommendations for reducing crime and violence. Individualized nutrient therapy treatments that have produced thousands of reports of recovery are presented along with several case histories. This modality is more scientific than trial-and-error use of psychiatric drugs, and is aimed at true normalization of the brain. More than 90 Australian physicians have been trained in this modality.
Epigenetics is a word unfamiliar to most Australians, but will soon be known to everyone. This emerging science is steadily revealing the causes of many of the world’s most challenging medical disorders, such as cancer and heart disease, and is providing a roadmap for development of vastly improved therapies. In an exciting development, new research indicates that many mental disorders also appear to be epigenetic in nature, and that improved treatments may be in the offing for schizophrenia, clinical depression, autism, ADHD, and criminal behaviour. Moreover, there is a good chance that these new therapies will be based on natural substances rather than drug medications.
Epigenetics is a somewhat complicated subject and my book provides a detailed description of the processes involved and their impacts on brain function. There are more than a trillion cells in the human body, and each cell contains an identical copy of a person’s DNA. However, gene expression rates in brain, kidney, skin, heart and other tissues must be different for survival, and gene programming is established during the first few months of fetal development to accomplish this objective. In order to obtain the correct mix of enzymes and proteins in different organs, some genes are selectively “turned off” and others “turned on”. This process is called epigenetics, which means “above genetics”.
We are now learning that many diseases thought to be genetic are instead epigenetic in nature. The culprit is usually an environmental insult that alters gene expression “bookmarks” either in utero or later in life. Since deviant bookmarks can survive many cell divisions, the disorder doesn’t go away. There is considerable evidence that epigenetic errors are responsible for mental breakdowns experienced in schizophrenia, bipolar disorder, the sudden emergence of OCD, and the striking symptoms associated with regressive autism. It appears that deviant epigenetic bookmarks may be reversed by future therapies. In some cases, this could result in a permanent cure requiring no additional treatment. I hope epigenetics research aimed at mental disorders will become a major priority throughout the world.
My book asserts that today’s emphasis on prescription medications will not stand the test of time, and that the field of psychiatry needs a new direction. Psychiatric drugs suffer from a fundamental limitation – Introduction of foreign molecules that result in an abnormal condition rather than producing normalcy. Recent advances in epigenetics and the molecular biology of the brain have provided a roadmap for the development of effective, natural, drug-free therapies that do not produce serious side effects. An intensive research effort is needed to develop advanced epigenetic therapies that use chemicals natural to the body to normalize brain function, and thus avoid the nagging problem of drug side effects. Psychiatric medications have served society well over the past 50 years, but the need for drug therapies will gradually fade away as brain science advances. I believe we may be approaching a grand new era in the field of mental health.
About the author: Dr. William J. Walsh is president of the non-profit Walsh Research Institute in Illinois and directs physician-training programs in Australia, Norway, and other countries. Dr. Walsh has authored more than 200 scientific articles and reports and has five patents. He has presented his experimental research at the American Psychiatric Association, the U.S. Senate, the National Institutes of Mental Health, and has been a speaker at 28 international conferences. He has developed biochemical treatments for patients with behavioural disorders, ADHD, autism, depression, anxiety disorders, schizophrenia, and Alzheimer’s disease that are used by doctors throughout the world.